@k6
"Compensation is drawn from a shrinking pool and routed through HR"
I wonder why...
https://www.beckerspayer.com/payer/elevance-healths-5-highest-paid-executives-2025/
Gail Boudreaux, president and CEO
Salary: $1,600,000
Stock awards: $12,600,032
Option awards: $4,199,989
Non-equity incentive plan: $1,142,400
Other compensation: $929,555
Total compensation: $20,471,976
Mark Kaye, executive vice president and CFO
Salary: $900,000
Stock awards: $4,125,144
Option awards: $1,374,953
Non-equity incentive plan: $385,560
Other compensation: $87,487
Total compensation: $6,873,144
Peter Haytaian, executive vice president and president of Carelon and CarelonRx
Salary: $950,000
Stock awards: $3,600,081
Option awards: $1,199,997
Non-equity incentive plan: $406,980
Other compensation: $188,069
Total compensation: $6,345,127
Felicia Norwood, executive vice president and president of government health benefits
Salary: $950,000
Stock awards: $3,600,081
Option awards: $1,199,997
Non-equity incentive plan: $406,980
Other compensation: $131,888
Total compensation: $6,288,946
Morgan Kendrick, executive vice president and president of commercial and specialty health benefits
Salary: $850,000
Stock awards: $3,225,249
Option awards: $1,074,825
Non-equity incentive plan: $510,000
Other compensation: $133,400
Total compensation: $5,793,474
Heaven forbid a multimillionaire take a slightly lower increase, to provide raises for much poorer employees.